- Clinical Trials Members
- Meetings & Education
- Committees / Compliance / Resources
- Disease Site & IND Committees
- Disease Site Committees Overview
- Disease Site Executive Committees Overview
- Investigational New Drug (IND) Committee Overview
- IND Executive Committee Overview
- Brain Disease Site Committee
- Breast Disease Site Committee
- Gastro-Intestinal Disease Site Committee
- Genito-Urinary Disease Site Committee
- Gynecologic Disease Site Committee
- Head & Neck Working Group
- Hematologic Disease Site Committee
- IND Disease Site Committee
- Lung CSTB Working Group
- Melanoma Disease Site Committee
- Sarcoma Disease Site Committee
- Symptom Control Disease Site Committee
- Standing Committees
- Clinical Trials Committee
- Data Safety Monitoring Committee(DSMC)
- Quality of Life Committee
- Correlative Sciences and Tumour Biology Committee
- Committee on Economic Analysis
- Patient Representatives
- Audit & Monitoring Committee
- CRA Executive Committee
- CRA Committee
- Pharmacists Network
- Radiation Oncology Quality Assurance Committee
- IND Program
- Office of Compliance and Oversight
- Correlative Science / Tumour Bank
- Revised RECIST guideline
- Key Contacts
- Funding Information
- Monthly Site Accrual
- Useful Links
- Canadian Cancer Trials Group Generic Protocol